Scientists at the German Center for Neurodegenerative Diseases (DZNE) have identified a group of proteins that help to regenerate damaged nerve cells. Their findings are reported in the journal Neuron.
Aug 7, 2019
0
636
The brains of millions of people suffering from Alzheimer's disease are slowly and inescapably being depleted of neurons, but the cause of neuronal death is still unknown. Several studies propose that the interaction of the ...
Sep 14, 2016
0
3
Alzheimer's disease is the most common form of dementia, affecting over 44 million people worldwide. Inside the brain, Alzheimer's disease is characterized by loss of neurons, and presence of abnormal tangles and plaques ...
May 27, 2015
0
18
Massachusetts General Hospital (MGH) researchers have identified and validated two rare gene mutations that appear to cause the common form of Alzheimer's disease (AD) that strikes after the age of 60. The two mutations occur ...
Sep 24, 2013
0
0
A new study by Valerie Hu, Ph.D., professor of biochemistry and molecular medicine at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), reports that RORA, a novel candidate gene for autism ...
Jul 1, 2013
0
0
A line of genetically modified mice that Western University scientists call "Forrest Gump" because, like the movie character, they can run far but they aren't smart, is furthering the understanding of a key neurotransmitter ...
Jun 20, 2013
0
0
A new study provides surprising evidence that people with narcolepsy have an increased number of neurons that produce histamine, suggesting that histamine signaling may be a novel therapeutic target for this potentially disabling ...
Jun 3, 2013
2
2
(Medical Xpress)—A team led by Dr. Alex Parker, a professor of pathology and cellular biology and a researcher at the University of Montreal Hospital Research Centre (CRCHUM), has identified an important therapeutic target ...
Apr 17, 2013
0
0
A new study published in the March issue of The American Journal of Pathology suggests that cortical type 2 cannabinoid (CB2) receptors might serve as potential therapeutic targets for cerebral ischemia.
Feb 21, 2013
0
0
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, and frontotemporal dementia (FTD) are devastating neurodegenerative diseases with no effective treatment. Researchers are beginning to recognize ALS and FTD as ...
Feb 12, 2013
0
0
